Aquestive Therapeutics
AQST
AQST
57 hedge funds and large institutions have $90M invested in Aquestive Therapeutics in 2020 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
57
Holders Change
+15
Holders Change %
+35.71%
% of All Funds
1.17%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
25
Increased
16
Reduced
9
Closed
9
Calls
$671K
Puts
$542K
Net Calls
+$129K
Net Calls Change
+$131K
Top Buyers
| 1 |
PA
Perceptive Advisors
New York
|
+$8.51M |
| 2 |
BlackRock
New York
|
+$5.9M |
| 3 |
State Street
Boston,
Massachusetts
|
+$1.4M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$926K |
| 5 |
Squarepoint
New York
|
+$862K |
Top Sellers
| 1 |
JPMorgan Chase & Co
New York
|
-$1.96M |
| 2 |
DCM
DG Capital Management
New York
|
-$1.2M |
| 3 |
EP
Eversept Partners
New York
|
-$657K |
| 4 |
Renaissance Technologies
New York
|
-$644K |
| 5 |
Millennium Management
New York
|
-$405K |
